SLI

SLI handeln
2.143,87 PKT +4,47 PKT +0,21 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN A0QZBF

ISIN CH0030252883


Analysen zu SLI-Werten

Datum Rating Analyst
11.08.17 Givaudan Underweight Barclays Capital
11.08.17 UBS buy HSBC
11.08.17 UBS buy Goldman Sachs Group Inc.
10.08.17 Zurich Insurance Hold S&P Capital IQ
10.08.17 Zurich Insurance Neutral UBS AG
10.08.17 UBS buy Citigroup Corp.
10.08.17 UBS buy Citigroup Corp.
09.08.17 Swiss Re overweight JP Morgan Chase & Co.
08.08.17 Nestlé overweight JP Morgan Chase & Co.
08.08.17 Givaudan overweight JP Morgan Chase & Co.
08.08.17 Holcim Neutral JP Morgan Chase & Co.
08.08.17 Holcim buy Citigroup Corp.
08.08.17 Roche Conviction Buy List Goldman Sachs Group Inc.
08.08.17 Novartis Neutral Goldman Sachs Group Inc.
07.08.17 Swiss Re overweight JP Morgan Chase & Co.
07.08.17 UBS neutral RBC Capital Markets
07.08.17 Swiss Re buy Goldman Sachs Group Inc.
07.08.17 Swiss Re kaufen DZ BANK
07.08.17 Swiss Re Sell UBS AG
07.08.17 Swiss Re buy Deutsche Bank AG
04.08.17 Novartis buy Baader Bank
04.08.17 Swiss Re Sell UBS AG
04.08.17 Swiss Re Hold S&P Capital IQ
04.08.17 Swiss Re Reduce Commerzbank AG
04.08.17 Swiss Re Hold Baader Bank
04.08.17 Swiss Re Outperform RBC Capital Markets
04.08.17 Swiss Re market-perform Bernstein Research
03.08.17 Nestlé buy Citigroup Corp.
03.08.17 Holcim Hold Deutsche Bank AG
03.08.17 UBS buy Deutsche Bank AG
01.08.17 UBS buy Citigroup Corp.
01.08.17 UBS overweight JP Morgan Chase & Co.
01.08.17 UBS overweight JP Morgan Chase & Co.
01.08.17 Zurich Insurance Neutral JP Morgan Chase & Co.
31.07.17 Roche overweight JP Morgan Chase & Co.
31.07.17 UBS Neutral Credit Suisse Group
31.07.17 UBS overweight JP Morgan Chase & Co.
31.07.17 UBS buy Goldman Sachs Group Inc.
31.07.17 UBS Neutral Goldman Sachs Group Inc.
28.07.17 Holcim Hold Deutsche Bank AG